About Synthace
Synthace is a company based in London (United Kingdom) founded in 2011 by Markus Christian Gershater.. Synthace has raised $80.27 million across 8 funding rounds from investors including Horizons Ventures, Sofinnova Partners and SOSV. The company has 68 employees as of December 31, 2020. Synthace offers products and services including Synthace Software, DOE Training Course, and Dilution Calculator. Synthace operates in a competitive market with competitors including Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and CrelioHealth, among others.
- Headquarter London, United Kingdom
- Employees 68 as on 31 Dec, 2020
- Founders Markus Christian Gershater
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synthace Limited
- Date of Incorporation 31 May, 2011
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
$2.41 M (USD)47as on Jan 31, 2023
-
Net Profit
$-11.58 M (USD)-7as on Jan 31, 2023
-
EBITDA
$-13.47 M (USD)-5as on Jan 31, 2023
-
Total Equity Funding
$80.27 M (USD)
in 8 rounds
-
Latest Funding Round
$35 M (USD), Series C
Nov 16, 2021
-
Investors
Horizons Ventures
& 8 more
-
Employee Count
68
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synthace
Synthace offers a comprehensive portfolio of products and services, including Synthace Software, DOE Training Course, and Dilution Calculator. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for automating and optimizing biological experiments.
Training on Design of Experiments for scientific research.
Online tool for accurate dilution calculations in labs.
Unlock access to complete
Unlock access to complete
Funding Insights of Synthace
Synthace has successfully raised a total of $80.27M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series C — $35.0M
-
First Round
First Round
(12 Apr 2012)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series C - Synthace | Valuation | Horizons Ventures , Sofinnova Partners |
|
| Dec, 2018 | Amount | Series B - Synthace | Valuation | Horizons Ventures | |
| May, 2018 | Amount | Series A - Synthace | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synthace
Synthace has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include Horizons Ventures, Sofinnova Partners and SOSV. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Horizons Ventures is focused on investing in deep science and technology.
|
Founded Year | Domain | Location | |
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synthace
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Synthace
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synthace Comparisons
Competitors of Synthace
Synthace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and CrelioHealth, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of laboratory management system for researchers and clinicians
|
|
| domain | founded_year | HQ Location |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based remote lab automation software is offered for life sciences.
|
|
| domain | founded_year | HQ Location |
Lab management platform for life sciences is offered by Quartzy.
|
|
| domain | founded_year | HQ Location |
SaaS-based laboratory information system is provided for clinicians.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synthace
Frequently Asked Questions about Synthace
When was Synthace founded?
Synthace was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Synthace located?
Synthace is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Synthace?
Markus Christian Gershater is the current CEO of Synthace. They have also founded this company.
Is Synthace a funded company?
Synthace is a funded company, having raised a total of $80.27M across 8 funding rounds to date. The company's 1st funding round was a Series A of $3.1M, raised on Apr 12, 2012.
How many employees does Synthace have?
As of Dec 31, 2020, the latest employee count at Synthace is 68.
What is the annual revenue of Synthace?
Annual revenue of Synthace is $2.41M as on Jan 31, 2023.
What does Synthace do?
Synthace was founded in 2011 in London, United Kingdom, within the biotechnology sector. SaaS-based software for laboratory automation is offered to researchers, enabling experiment automation through products like Antha. An interoperable system is included for error detection and can be reprogrammed to manage liquid handling in biological experiments. Operations focus on streamlining research workflows across global labs.
Who are the top competitors of Synthace?
Synthace's top competitors include Tecan, Waters Corporation and Automata.
What products or services does Synthace offer?
Synthace offers Synthace Software, DOE Training Course, and Dilution Calculator.
Who are Synthace's investors?
Synthace has 9 investors. Key investors include Horizons Ventures, Sofinnova Partners, SOSV, Luminous Ventures, and Amadeus Capital Partners.
What is Synthace's valuation?
The valuation of Synthace is $71.3M as of Dec 2018.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.